The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
420 jobs Number of planned job losses
Announcement Date
11 September 2007
Employment effect (start)
11 September 2007
Foreseen end date
30 September 2009
Description
Pfizer, a multi-national pharmaceutical firm, has announced that it is to close its manufacturing site in Sandwich, Kent, with the loss of 420 jobs. The company has stated the decision was the result of ongoing consolidation of its global manufacturing operations. Pfizer has also cut jobs in sales, and research and development (R&D), since 2005. Its European R&D headquarters remain in Sandwich, employing 3,500 people.
Pfizer stated that the job losses would be phased in until September 2009.
Tony Maddaluna, vice-president of Pfizer Global Manufacturing, stated: 'It is with regret that we announce our decision to end manufacturing operations in Sandwich after 53 years. This is the latest in a number of global manufacturing changes, to ensure we are operating as efficiently and effectively as possible.'
Pfizer said it would work closely with other bodies to 'mitigate the impact on colleagues and the local community', especially offering support for redeployment or re-training.
Mr Ladyman, Labour MP for South Thanet, said: 'I know Pfizer will do its best to redeploy as many people as possible, but that will be little comfort to those who will lose their jobs. The hard-working men and women have made a massive contribution to the growth of Pfizer... and this is no way for the company to treat them.'
Pfizer said the closure was no reflection on the performance of a 'talented and skilled workforce'.
Sources
11 September 2007: BBC Website
Citation
Eurofound (2007), Pfizer, Closure in United Kingdom, factsheet number 65794, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/65794.
Eurofound’s ERM restructuring legislation database offers an overview of key restructuring-related regulations in the EU Member States and Norway. Its content is continuously updated to reflect any changes made by national legislators in response to, for instance, policy shifts, legal...
Can Europe still achieve its ambitions for battery manufacturing? To answer this, the article looks at data from Eurofound’s European Restructuring Monitor and explores what recent large-scale restructuring events reveal about the state of play in the EU battery sector.
This working paper offers a comprehensive methodological overview of the European Restructuring Monitor (ERM) databases. Even though the methodology has not changed over time, new categories have been added, and the way it has been used by researchers and policymakers...
This Eurofound research paper explores key trends in restructuring in recent years, highlighting the companies that announced the largest job losses and job gains in the EU. It builds on an analysis of company announcements recorded in Eurofound’s European Restructuring...
In 2023, thousands of workers in big tech lost their jobs. Meta, Amazon, Google, Apple, Microsoft and Salesforce had been considered to offer good and secure jobs up to this point. Giants of the information and communication technology (ICT) sector,...
In 2024, the automotive sector in the EU came to the fore in public and policy discussions. The focus was on the slowdown in electric vehicle (EV) sales, rising global competition, belated investments in new technologies, and the potential closure...